awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43707361-29FB07CC-411E-4FBE-AEF9-2CD102C4C676
Q43707361-29FB07CC-411E-4FBE-AEF9-2CD102C4C676
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43707361-29FB07CC-411E-4FBE-AEF9-2CD102C4C676
High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.
P2860
Q43707361-29FB07CC-411E-4FBE-AEF9-2CD102C4C676
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43707361-29FB07CC-411E-4FBE-AEF9-2CD102C4C676
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1f5c994d9ec0775ec36c4380aab0d7e7878edeb1
P2860
Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells